New Worries About A New Rheumatoid Arthritis Drug

By Mark Borigini, M.D., Health Pro Wednesday, January 31, 2007

- A
- A
- A

On December 19, 2006, the United States Food and Drug Administration issued an “Alert” regarding the safety of Rituxan use in patients suffering from rheumatologic illnesses.This alert was issued because there were two reported cases of fatal Progressive Multifocal Leukoencepholopathy, more con...

Read the rest of this post >>

Prednisone, the Dirty Little Secret, Becomes More Respectable

Hide Comments | Add comment

Maria

9/23/07 7:45am

I am a rheumatoid arthritis patient considering Rituxan treatment and although the statistics support that PML is rare in the RA population, it gives one pause before beginning treatment.

Related Rheumatoid Arthritis Topics

By Mark Borigini, M.D., Health Pro— Last Modified: 12/03/10, First Published: 01/31/07

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

New Worries About A New Rheumatoid Arthritis Drug

Ask a Question